Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

260
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
260
Rh Blood Group01:19

Rh Blood Group

1.2K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.2K
Hematopoiesis01:21

Hematopoiesis

4.9K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
4.9K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

3.6K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
3.6K
Teratogenicity01:07

Teratogenicity

2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

1.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
1.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Readmission and Late Mortality Among Children With Congenital Diaphragmatic Hernia.

JAMA network open·2026
Same author

High-intensity immunosuppression versus modern standard care in poor-prognosis diffuse cutaneous systemic sclerosis: A propensity-matched study.

Journal of autoimmunity·2026
Same author

Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA group.

HemaSphere·2026
Same author

Focus on the bleeding risk of elderly patients with myelodysplastic syndromes.

Journal of thrombosis and haemostasis : JTH·2026
Same author

High frequency of CD95<sup>+</sup>/CD45RA<sup>-</sup> regulatory T cells defines an immunosuppressive profile associated with MDS progression.

British journal of haematology·2026
Same author

Management of preterm pre-labor rupture of membranes between 24 and 34 weeks: A before-and-after study of the implementation and modifications of an outpatient management protocol.

Acta obstetricia et gynecologica Scandinavica·2026

相关实验视频

Updated: May 10, 2025

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

1.9K

[怀孕中的血液性恶性瘤]

Justine Decroocq1, Sangsong Wu1, Mathilde Barrois2

  • 1Service d'hématologie clinique, Hôpital Cochin-Port Royal (AP-HP), Institut Cochin, Université Paris Cité, Paris, France.

Medecine sciences : M/S
|April 28, 2025
PubMed
概括

在怀孕期间管理血液性恶性瘤是复杂的,需要针对孕产妇和胎儿风险进行多学科的护理. 更多的研究对于优化治疗和患者进入临床试验至关重要.

更多相关视频

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

27.9K
Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
08:53

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes

Published on: January 10, 2025

380

相关实验视频

Last Updated: May 10, 2025

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

1.9K
Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

27.9K
Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
08:53

Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes

Published on: January 10, 2025

380

科学领域:

  • 血液学 血液学 血液学
  • 产科 产科 产科 产科 产科
  • 在瘤学瘤学.

背景情况:

  • 怀孕期间的血液性恶性瘤很少见,并带来了重大挑战.
  • 管理需要平衡母亲的生理变化与治疗对胎儿的风险.
  • 目前仅有有限的数据可指导最佳的患者护理策略.

研究的目的:

  • 概述在怀孕期间管理血液性恶性瘤的复杂性.
  • 突出诊断,治疗和预后方面的挑战.
  • 强调需要全面的研究和患者参与临床试验的必要性.

主要方法:

  • 文献综述和现有知识的综合在怀孕期间血液恶性瘤.
  • 对诊断,治疗和预后考虑的分析.
  • 讨论多学科合作的要求.

主要成果:

  • 怀孕使血液恶性瘤的管理复杂化,原因是孕产妇和胎儿的风险.
  • 治疗决策需要仔细考虑对母亲和胎儿的潜在不良影响.
  • 有限的研究阻碍了基于证据的护理优化.

结论:

  • 有效的管理需要多学科的方法,包括血液学家,瘤学家和产科医生.
  • 进一步的研究对于改善理解,治疗影响评估和护理优化至关重要.
  • 让孕妇参与临床试验是改善获得新疗法的关键.